ACC CardiaCast: Pulse Check: What’s New in Lipid Management for the Pharmacist CV Team Professional?
PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to ...
In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart ...
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode two of four, Dr. Tom Draper talks with Mr. Adam DeJong and Dr. Malissa Wood about efforts required in the ...
Can algorithms improve the management of patients with myocardial injury? Is there a tool to aid diagnosing patients faster ...
Participation in ACC’s Reduce the Risk: PCI Bleed Campaign was associated with a significant reduction of bleeding events following PCI, according to a study published in Circulation: Cardiovascular ...
The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule and the 2025 Hospital Outpatient Prospective Payment System (OPPS) and ...
Benali K, Ninni S, Guenancia C, et al. After propensity score matching, patients who underwent catheter ablation (n = 288) and those treated with medical therapy alone (n = 288) did not present any ...
Herzig MS, Kennedy KF, Hawkins BM, Secemsky EA. The authors examined all patients undergoing peripheral vascular intervention for the indication of ALI in the National Cardiovascular Data Registry ...
A biodegradable polymer sirolimus-eluting stent (BP-SES) was noninferior to currently-used second-generation drug-eluting stents (DES) in terms of target lesion failure (TLF) at one year in patients ...
Wolfe NK, Schiff MD, Christopher AB, et al., on behalf of FORCE Investigators. The study made use of the FORCE (Fontan Outcomes Registry Using CMR Examinations) registry, which collects clinical and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback